🕵️ Bionano Genomics, Inc. ($BNGO)
SEC insider & ownership activity, last 12 months · CIK 1411690 · every row links its SEC filing
Over the last 12 months insiders bought $10K with no open-market selling against it. Luderer Albert bought $10K in discretionary trades (Aug–Sep). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $10K (2 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Luderer Albert | 2 | $10K | 0 | – | Sep 4, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Ayrton Capital LLC | 10.0% | 13G | Nov 13, 2025 | filing ↗ | |
| ALTO Opportunity Master Fund, SPC - Segregated Master Portfolio B | 10.0% | 13G | Nov 13, 2025 | filing ↗ | |
| Waqas Khatri | 10.0% | 13G | Nov 13, 2025 | filing ↗ | |
| CVI Investments, Inc. | 9.9% | 13G | Aug 14, 2026 | filing ↗ | |
| Heights Capital Management, Inc. | 9.9% | 13G | Aug 14, 2026 | filing ↗ | |
| Jeff Easton | 9.9% | 13G | Sep 24, 2025 | filing ↗ | |
| LIND Global Fund III LP | 9.3% | 13G | Feb 17, 2026 | filing ↗ | |
| LIND Global Partners III LLC | 9.3% | 13G | Feb 17, 2026 | filing ↗ | |
| Easton Jeff | 9.3% | 13G | Feb 17, 2026 | filing ↗ | |
| Lincoln Alternative Strategies LLC | 5.4% | 13G | Sep 17, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Sep 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 14, 2026 | filing ↗ |
| Earnings (2.02) | Aug 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 10, 2026 | filing ↗ |
| Other events (8.01) | Jun 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 24, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 2, 2026 | filing ↗ |
| Other events (8.01) | May 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 28, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 14, 2026 | filing ↗ |
| Earnings (2.02) | May 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 13, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 5, 2026 | filing ↗ |
| Other events (8.01) | May 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing ↗ |
| Earnings (2.02) | Mar 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 23, 2026 | filing ↗ |
| Earnings (2.02) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Earnings (2.02) | Nov 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 13, 2025 | filing ↗ |
| Material agreement (1.01) | Sep 16, 2025 | filing ↗ |
| Other events (8.01) | Sep 16, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 16, 2025 | filing ↗ |